A European Respiratory Society research seminar on “Metabolic alterations in obstructive
sleep apnoea (OSA)” was jointly organised in October 2009 together with two EU COST …

Obstructive sleep apnoea (OSA) is a highly prevalent condition often associated with central
obesity. In the past few years, several studies have analysed the potential independent …

Obstructive sleep apnea (OSA) is characterized by upper airway collapse during sleep.
Chronic intermittent hypoxia, sleep fragmentation, and inflammatory activation are the main …

Obstructive sleep apnoea (OSA) seems to worsen metabolism. This effect has not been
evaluated in morbid obesity (MO). We hypothesised that the metabolic profile is more …

Obstructive sleep apnoea (OSA) is associated with multiple cardiometabolic abnormalities.
Obesity is considered a major risk factor for the development of OSA, and it is also an …

Obesity is the most powerful risk factor for obstructive sleep apnea (OSA), and it is
essentially the only reversible one. OSA and obesity share common substrates, pathologic …

Sleep profoundly affects metabolic pathways. In healthy subjects, experimental sleep
restriction caused insulin resistance (IR) and increased evening cortisol and sympathetic …

Metabolic syndrome (MS), the commonly used term for the clustering of obesity, insulin
resistance, hypertension, and dyslipidemia, affects millions of people worldwide, and is …

Obstructive sleep apnea (OSA) is an underdiagnosed condition characterized by recurrent
episodes of obstruction of the upper airway leading to sleep fragmentation and intermittent …

Obstructive sleep apnea (OSA) is an increasingly prevalent sleep disorder characterized by
upper airway obstruction during sleep, resulting in breathing pauses, intermittent hypoxia …